Adebiot Cap

Alterations in Intestinal Microbiota Composition with ADEBITE Correlated With Positive Health Benefits

Administration of ADEBITE protect the mucosal barrier by :
• Supporting the number of short-chain fatty acid producers
• Decreasing the load of potentially harmful bacteria
• Reducing intestinal inflammation and abdominal discomfort.

There is substantial evidence to support Adebite use in the treatment of:
• Acute diarrheal diseases
• Prevention of antibiotic-associated diarrhea
• Improvement of lactose metabolism
• Improvement of intestinal health
• Enhancement of the immune response
• Reduction of serum cholesterol
• Cancer prevention.
• Adebite improved symptoms and increased rectal pain thresholds.